Delivery Order SPE2DB24D3015-SPE2DB26FFWUX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,923.46 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a completion date of October 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order transaction under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,273.24 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with an ultimate completion date of October 30, 2025. This non-competitive delivery order was issued under a firm fixed-price arrangement and represents a continuation of the federal government's pharmaceutical procurement needs through established contract vehicles. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,615.86 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This firm fixed-price delivery order, issued on May 15, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by May 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,058.52 for Mesalamine DR 1.2 GM tablets (120 count) on July 10, 2025, with an ultimate completion date of July 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,577.50 to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the awardee's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary distribution hub...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mesalamine DR 1.2 GM tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $1,556.04, with an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,083.24 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count). This is a firm fixed-price delivery order with a completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $5,366.85 delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,421.08 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This firm fixed-price delivery order, with an ultimate completion date of October 30, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $2,170.31 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) on June 18, 2025, with completion scheduled for June 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB26FFWUXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,040.77 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a completion date of October 31, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on October 30, 2025, and performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999.999 billion through December 2026. AmerisourceBergen serves as a prime vendor in the Defense Logistics Agency's medical supply chain, providing a broad range of pharmaceutical products and medical supplies to support military healthcare programs and other federal healthcare systems. The Mesalamine delivery represents a routine pharmaceutical fulfillment under this expansive IDC framework, which enables the contractor to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 10/30/25 |